206 related articles for article (PubMed ID: 18172537)
1. Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery.
Mahmoud A; Al-Ruzzeh S; McKeague H; Cross M
Tex Heart Inst J; 2007; 34(4):485-8. PubMed ID: 18172537
[TBL] [Abstract][Full Text] [Related]
2. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
3. Deep vein thrombosis after recombinant factor VIIa infusion to control severe recurrent postoperative bleeding.
Pépion C; Becq MC; Jacob L
Anesthesiology; 2006 Apr; 104(4):892-3. PubMed ID: 16571994
[No Abstract] [Full Text] [Related]
4. Was systemic venous thrombosis really due to the administration of recombinant factor VIIa? or was it possibly a manifestation of Lemierre syndrome?
Saeed G; Ganster G; Friedel N
Tex Heart Inst J; 2008; 35(3):373-4; author reply 374-6. PubMed ID: 18941643
[No Abstract] [Full Text] [Related]
5. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
[TBL] [Abstract][Full Text] [Related]
6. Con: The role of recombinant factor VIIa in the control of bleeding after cardiac surgery.
Al-Ruzzeh S; Ibrahim K; Navia JL
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):783-5. PubMed ID: 18922443
[No Abstract] [Full Text] [Related]
7. [Recombinant activated factor VII for perioperative bleeding].
López R; Aeschlimann N; Carvajal C; Lema G
Rev Med Chil; 2009 Jun; 137(6):837-43. PubMed ID: 19746288
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis.
Karkouti K; Beattie WS; Wijeysundera DN; Yau TM; McCluskey SA; Ghannam M; Sutton D; van Rensburg A; Karski J
Transfusion; 2005 Jan; 45(1):26-34. PubMed ID: 15647015
[TBL] [Abstract][Full Text] [Related]
9. Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery.
Johnson SJ; Ross MB; Moores KG
Am J Health Syst Pharm; 2007 Sep; 64(17):1808-12. PubMed ID: 17724361
[TBL] [Abstract][Full Text] [Related]
10. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
11. Pediatric off-label use of recombinant factor VIIa.
Alten JA; Benner K; Green K; Toole B; Tofil NM; Winkler MK
Pediatrics; 2009 Mar; 123(3):1066-72. PubMed ID: 19255041
[TBL] [Abstract][Full Text] [Related]
12. Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa.
Mazer CD; Leong-Poi H; Mahoney J; Latter D; Strauss BH; Teitel JM
Semin Cardiothorac Vasc Anesth; 2007 Dec; 11(4):261-4. PubMed ID: 18270189
[TBL] [Abstract][Full Text] [Related]
13. Successful graft patency after factor VIIa use for bleeding in coronary artery surgery: an unusual complication of a coronary artery bypass surgery.
Wahed S; Karagounis AP; Niranjan G; Kanagasabay R
J Card Surg; 2007; 22(5):424-7. PubMed ID: 17803583
[TBL] [Abstract][Full Text] [Related]
14. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
[TBL] [Abstract][Full Text] [Related]
15. [Risk assessment of thrombotic events after the use of activated factor VII].
Martínez López MC; Alcaraz Romero AJ; Martínez López AB; Fernández-Llamazares CM; Ramos Navarro C
An Pediatr (Barc); 2013 Sep; 79(3):177-81. PubMed ID: 23265723
[TBL] [Abstract][Full Text] [Related]
16. Pro: The role of recombinant factor VIIa in cardiac surgery.
Karkouti K; Beattie WS
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):779-82. PubMed ID: 18922442
[No Abstract] [Full Text] [Related]
17. Unlabeled uses of factor VIIa (recombinant) in pediatric patients.
Hong I; Stachnik J
Am J Health Syst Pharm; 2010 Nov; 67(22):1909-19. PubMed ID: 21048207
[TBL] [Abstract][Full Text] [Related]
18. Successful management of bleeding with recombinant factor VIIa (NovoSeven) in a patient with Burkitt lymphoma and thrombosis of the left femoral and left common iliac veins.
Culić S; Kuljis D; Armanda V; Jankovic S
Pediatr Blood Cancer; 2007 Sep; 49(3):332-5. PubMed ID: 16514611
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery.
von Heymann C; Hotz H; Konertz W; Kox WJ; Spies C
J Cardiothorac Vasc Anesth; 2002 Oct; 16(5):615-6. PubMed ID: 12407617
[No Abstract] [Full Text] [Related]
20. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery.
Gill R; Herbertson M; Vuylsteke A; Olsen PS; von Heymann C; Mythen M; Sellke F; Booth F; Schmidt TA
Circulation; 2009 Jul; 120(1):21-7. PubMed ID: 19546387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
